Marked biochemical difference in amyloid proportion between intra- and extraocular tissues in a liver-transplanted patient with hereditary ATTR amyloidosis

References

• Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002;58:1001–7
   PubMed Web of Science ®Google Scholar
• Holmgren G, Steen L, Ekstedt J, Groth CG, Ericzon BG, Eriksson S, Andersen O, et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP me30). Clin Genet 1991;40:242–6
   PubMed Web of Science ®Google Scholar
• Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, Harihara Y, et al. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun 2000;274:702–6
   PubMed Web of Science ®Google Scholar
• Yazaki M, Mitsuhashi S, Tokuda T, Kametani F, Takei Y, Koyama J, Kawamorita A, et al. Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients. Am J Transplant 2007;7:235–42
   PubMed Web of Science ®Google Scholar
• Ando Y, Ando E, Tanaka Y, Yamashita T, Tashima K, Suga M, Uchino M, et al. De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation. Transplantation 1996;62:1037–8
   PubMed Web of Science ®Google Scholar
• Ando E, Ando Y, Haraoka K. Ocular amyloid involvement after liver transplantation for polyneuropathy. Ann. Intern. Med 2001;135:931–2
   PubMed Web of Science ®Google Scholar
• Salvi F, Pastorelli F, Plasmati R, Morelli C, Rapezzi C, Bianchi A, Mascalchi M. Brain microbleeds 12 years after orthotopic liver transplantation in Val30Met amyloidosis. J Stroke Cerebrovasc Dis 2015;24:e149–51
   PubMed Web of Science ®Google Scholar
• Sekijima Y, Yazaki M, Oguchi K, Ezawa N, Yoshinaga T, Yamada M, Yahikosawa H, et al. Cerebral amyloid angiopathy in posttransplant patients with hereditary ATTR amyloidosis. Neurology 2016;87:773–81
   PubMed Web of Science ®Google Scholar
• Hara R, Kawaji T, Ando E, Ohya Y, Ando Y, Tanihara H. Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients. Arch Ophthalmol 2010;128:206–10
   PubMedGoogle Scholar
• Munar-Qués M, Salvá-Ladaria L, Mulet-Perera P, Solé M, López-Andreu FR, Saraiva MJ. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Amyloid 2000;7:266–9
   PubMed Web of Science ®Google Scholar
• Liepnieks JJ, Phan ADT, Wise RJ, Hrisomalos FN, Benson MD. Biochemical characterization of vitreous amyloid formed after liver transplantaion. Amyloid 2016;23:136–7
   PubMed Web of Science ®Google Scholar
• Cavallaro T, Martone RL, Dwork AJ, Schon EA, Herbert J. The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye. Invest Ophthalmol Vis Sci 1990;31:497–501
   PubMed Web of Science ®Google Scholar
• Kawaji T, Ando Y, Nakamura M, Yamamoto K, Ando E, Takano A, Inomata Y, et al. Transthyretin synthesis in rabbit ciliary pigment epithelium. Exp Eye Res 2005;81:306–12
   PubMed Web of Science ®Google Scholar
• Pras M, Schubert M, Zucker-Franklin D, Rimon A, Franklin EC. The characterization of soluble amyloid prepared in water. J Clin Invest 1968;47:924–33
   PubMed Web of Science ®Google Scholar
• Haraoka K, Ando Y, Ando E, Sandgren O, Hirata A, Nakamura M, Terazaki H, et al. Amyloid deposition in ocular tissues of patients with familial amyloidostic polyneuropathy (FAP). Amyloid 2002;9:183–9
   PubMed Web of Science ®Google Scholar
• Gustavsson A, Engström U, Westermark P. Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations. Am J Pathol 1994;144:1301–11
   PubMed Web of Science ®Google Scholar
• Sethi S, Theis JD, Vrana JA, Fervenza FC, Sethi A, Qian Q, Quint P, et al. Laser microdissection and proteomic analysis of amyloidosis, cryoglobulinemic GN, fibrillary GN, and immunotoctoid glomerulopathy. Clin J AM Soc Nephrol 2013;8:915–21
   PubMed Web of Science ®Google Scholar
• Kametani F, Haga S. Accumulation of carboxy-terminal fragments of APP increases phosphodiesterase 8B. Neurobiol Aging 2015;36:634–7
   PubMed Web of Science ®Google Scholar
• Yoshinaga T, Yazaki M, Sekijima Y, Kametani F, Miyashita K, Hachiya N, Tanaka T, et al. The pathological and biochemical identification of possible seed-lesions of transmitted transthyretin amyloidosis after domino liver transplantation. J Path Clin Res 2016;2:72–9
   PubMedGoogle Scholar
• Kawaji T, Ando Y, Nakamura M, Yamashita T, Wakita M, Ando E, Hirata A, et al. Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C. Ophthalmology 2005;112:2212–18
   PubMed Web of Science ®Google Scholar
• Beirão JM, Moreira LV, Lacerda PC, Vitorino RP, Beirão IB, Torres PA, Costa PP. Inability of mutant transthyretin V30M to cross the blood–eye barrier. Transplantation 2012;94:e54–6
   PubMed Web of Science ®Google Scholar
• Haraoka K, Ando Y, Ando E, Sun X, Nakamura M, Terazaki H, Misumi S, et al. Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation. Amyloid 2002;9:247–51
   PubMed Web of Science ®Google Scholar
• Ando Y, Ando E, Ohlsson PI, Olofsson A, Sandgren O, Suhr O, Terazaki H, et al. Analysis of transthyretin amyloid fibrils from vitreous samples in familial amyloidotic polyneuropathy (Val30Met). Amyloid 1999;6:119–23
   PubMed Web of Science ®Google Scholar
• Liepnieks JJ, Wilson DL, Benson MD. Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis. Amyloid 2006;13:170–7
   PubMed Web of Science ®Google Scholar
• Beirão JM, Malheiro J, Lemos C, Matos E, Beirão I, Pinho-Costa P, Torres P. Impact of liver transplantation on the natural history of oculopathy in Portugese patients with transthyretin (V30M) amyloidosis. Amyloid 2015;22:31–5
   PubMed Web of Science ®Google Scholar